158 Chapter 7 22. Müller TD, Föcker M, Holtkamp K, Herpertz-Dahlmann B, Hebebrand J. Leptin-mediated neuroendocrine alterations in anorexia nervosa: somatic and behavioral implications. Child and adolescent psychiatric clinics of North America. 2009;18(1):117-29. 23. Miller KK, Wexler TL, Zha AM, Lawson EA, Meenaghan EM, Misra M, et al. Androgen deficiency: association with increased anxiety and depression symptom severity in anorexia nervosa. The Journal of clinical psychiatry. 2007;68(6):959-65. 24. Lawson EA, Donoho D, Miller KK, Misra M, Meenaghan E, Lydecker J, et al. Hypercortisolemia is associated with severity of bone loss and depression in hypothalamic amenorrhea and anorexia nervosa. J Clin Endocrinol Metab. 2009;94(12):4710-6. 25. Lawson EA, Holsen LM, Desanti R, Santin M, Meenaghan E, Herzog DB, et al. Increased hypothalamic-pituitary-adrenal drive is associated with decreased appetite and hypoactivation of food-motivation neurocircuitry in anorexia nervosa. Eur J Endocrinol. 2013;169(5):639-47. 26. Tiedemann LJ, Schmid SM, Hettel J, Giesen K, Francke P, Büchel C, Brassen S. Central insulin modulates food valuation via mesolimbic pathways. Nat Commun. 2017;8:16052. 27. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, et al. The fatderived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001;7(8):941-6. 28. Qi Y, Takahashi N, Hileman SM, Patel HR, Berg AH, Pajvani UB, et al. Adiponectin acts in the brain to decrease body weight. Nat Med. 2004;10(5):524-9. 29. Joshi YB, Praticò D. Lipid peroxidation in psychiatric illness: overview of clinical evidence. Oxid Med Cell Longev. 2014;2014:828702. 30. Perlemoine C, Macia F, Tison F, Coman I, Guehl D, Burbaud P, et al. Effects of subthalamic nucleus deep brain stimulation and levodopa on energy production rate and substrate oxidation in Parkinson’s disease. Br J Nutr. 2005;93(2):191-8. 31. Schneider M, Levant B, Reichel M, Gulbins E, Kornhuber J, Müller CP. Lipids in psychiatric disorders and preventive medicine. Neuroscience and biobehavioral reviews. 2017;76(Pt B):33662. 32. Lange KW. Omega-3 fatty acids and mental health. Global Health Journal. 2020;4(1):18-30. 33. Shimizu M, Kawai K, Yamashita M, Shoji M, Takakura S, Hata T, et al. Very long chain fatty acids are an important marker of nutritional status in patients with anorexia nervosa: a case control study. Biopsychosoc Med. 2020;14:14. 34. Oliveras-López MJ, Ruiz-Prieto I, BolañosRíos P, De la Cerda F, Martín F, JáureguiLobera I. Antioxidant activity and nutritional status in anorexia nervosa: effects of weight recovery. Nutrients. 2015;7(4):2193-208. 35. Fernandes MF, Mutch DM, Leri F. The Relationship between Fatty Acids and Different Depression-Related Brain Regions, and Their Potential Role as Biomarkers of Response to Antidepressants. Nutrients. 2017;9(3). 36. Caso JR, Graell M, Navalón A, MacDowell KS, Gutiérrez S, Soto M, et al. Dysfunction of inflammatory pathways in adolescent female patients with anorexia nervosa. Prog Neuropsychopharmacol Biol Psychiatry. 2020;96:109727. 37. Nelson JR, Raskin S. The eicosapentaenoic acid:arachidonic acid ratio and its clinical utility in cardiovascular disease. Postgrad Med. 2019;131(4):268-77. 38. Singh M. Essential fatty acids, DHA and human brain. Indian J Pediatr. 2005;72(3):239-42.
RkJQdWJsaXNoZXIy MjY0ODMw